Only unusual ways lead to unusual destinations!
For iREM, creating facts was possible only in the context of so-called compassionate (individual salvage) treatment. This “legal” freedom for a freelance researcher has now ended.
In the European Union, legal regulations render medical research a privilege for authorized circles only (Advanced Therapy Medicinal Products[ATMP], German Medicines Act[AMG], etc.). This monopolization not only limits research but also claims ethical evaluation. By the virtue of these regulations, unconventional research approaches are declared as “unscientific and unethical”, even criminalized. Thus, despite stunning positive results are neglected just because they don’t comply with these somehow unflexible regulations.
Apart fom these restrictoins patent legislation denies unfortunately the recognition of any medical treatment as intellectual property. It means legal protection for such achievement as iREM is not possible (for example German Patent Law, Chapter 2).
Health and suffering should never be commodities!
Although I believe that the excessive commercialization of disease treatment is a form of human rights violation, I cannot resist the following considerations: Thanks to politics and excessive capitalism, intellectual property can be protected in any form (e.g. pictures, music, designs, logos, software, etc.). This in itself is not reprehensible, as it is the reward for (mental, physical, financial, time) efforts, performance, commitment. However, in the field of medical research, any doctor or scientist is without protection – his findings are considered not to be patentable. As a justification, the doctor’s ethical and moral obligation to humanity is put forward. Still, this form of commitment does not apply to the pharmaceutical industry. Under the guise of “research and investment expenditure”, greed for profit is the order of the day – or how should it be called then if, for example, the sale of a single treatment dose for 2 million dollars is said to be morally justifiable? I call it reprehensible. But if this standard applies, it should be measured on the same scale – iREM as well must be recognized as intellectual property!
It is generally assumed that individual cancer treatments such as iREM are neither applicable for masses nor economically interesting. However, this may be a fatal mistake, as only devoted willpower and thoughtful organization is needed.
Suitable for mass application: With the necessary infrastructure, which can be set up relatively unproblematically by a state / the international community, iREM treatment can be implemented even in most remote regions – even without polluting the environment.
Economically interesting: In addition, with an immense number (many millions) of people affected worldwide, industry and business can benefit from the boom in the field of laboratory equipment and consumables; personnel requirements (doctors, biologists, laboratory assistants, technical maintenance staff, etc.) would create millions of new jobs worldwide. Furthermore, you should always keep an eye on a certain patent options that can be hidden in process steps of iREM treatment (!).
My suggestion: As mentioned above, the collection of “protection money” is perfectly organized all over the world. It is only legitimate to implement an analogous basis for medical procedures such as iREM as well, so that the intellectual performance of researchers is generally recognized. This is a matter of principle.
Since the American President Nixon proclaimed the “War on Cancer” in 1971, the world community has spent hundreds of billions of dollars to “win” the fight against cancer – with questionable success. Only the costs from the start of treatment to the death of cancer patients have increased from 4-digit dollar amounts to 6-digit figures. And still nations are prepared to spend more billions in research, perhaps merely an employment measure for academics. Are authorities indifferent to people suffering from cancer, as long as they hold back the chance that iREM provides?
Due to the above-mentioned strict guidelines, it is to be feared that researchers worldwide are unlikely to make any progress in the future. If anybody would be forced to obey official rules step by step, the realization of an idea like the iREM would take decades and millions of dollars. Therefore, independent and creative research strategies to cure cancer are urgently needed.